Stemline Therapeutics, Inc. announced the appointment of Robert M. Francomano as Chief Commercial Officer. Most recently, Mr. Francomano served as Senior Vice President, Global Head of Commercial and Medical Affairs for Stemline. Prior to this, Mr. Francomano garnered extensive oncology experience operating in global roles for Baxalta, Pfizer and GlaxoSmithKline, where he developed strategies for assets in clinical development from Phase I through Phase IV. His geographic responsibilities included the United States, the European Union, Latin America, and Asia-Pacific regions.